Research > ETFs > ETF / ETP Commentary > 

Time for AI Stocks to Show, Not Tell

When previously high-flying mega-cap artificial intelligence equities slumped in late July/early August, many market observers stated that the technology’s “show me” moment had arrived. What that means is that analysts and investors are starting to a demand much more from AI enablers and adopters than just long-term hope.They want to know that AI is making progress and that there are credible justifications to spend big on the goods and services purveyed by enablers. Should those scenarios there could be positive implications for exchange traded funds such as the Invesco QQQ Trust (QQQ B+) and the Invesco NASDAQ 100 ETF (QQQM B). Both ETFs track the Nasdaq-100 Index (NDX) – a gauge heavy on large- and mega-cap AI names, underscoring the funds’ leverage to the AI theme. One theme for QQQ/QQQM investors to stay abreast of is if the artificial intelligence adopters dwelling in the funds can justify related expenditures. “We expect AI to transition from a ‘tell me’ to a ‘show me’ story, with any disconnect between investments and revenue generation to come under increased scrutiny," according to Bank of America. “Overweight capex growers that fail to monetize quickly enough could be vulnerable to de-risking.”Time for More than AI Enablers to Get in GearFor much of the initial rally, the winning stocks were enablers, including semiconductor makers. That was good news for QQQ and QQQM, because the ETFs are home to a slew of chip stocks, including Nvidia (NVDA) and Broadcom (AVGO), among others. Now, analysts and investors are demanding broader, justifiable AI participation. That trend would almost certainly by other QQQ/QQQM holdings. Apple (AAPL) could be a prime example as it seeks to tap AI to juice iPhone sales. “At its Worldwide Developers Conference, or WWDC, Apple said it will integrate OpenAI’s ChatGPT into the Siri voice assistant and iOS 18. The big question is whether Apple ‘Intelligence’ features will spur a major iPhone 16 upgrade cycle in late 2024 and 2025,” reports Reinhardt Krause for Investor’s Businesss Daily (IBD). Software companies, of which plenty are found in QQQ and QQQM, are also seen as ripe for credible artificial intelligence adoption and benefits, but that could be a longer-ranging theme that requires investors’ patience. Currently, some of these firms are grappling with how to appropriately charge clients for AI products and services. “Further, most enterprise software makers will not monetize generative AI, or ‘conversational AI,’  in a material way until late 2025, some analysts say. Many U.S. companies are pursuing custom AI software development projects, which will take longer to ramp up commercially,” according to IBD. For more news, information, and analysis, visit the ETF Education Channel.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.